Woodford cancer treatment holding jumps 51%
Neil Woodford has seen his stake in an unquoted cancer treatment company jump $35.4m in his investment trust as it announces pricing on its initial public offering.
Neil Woodford has seen his stake in an unquoted cancer treatment company jump $35.4m in his investment trust as it announces pricing on its initial public offering.
Omnis Investments is extending its UK and Asia offerings as part of a wide-reaching fund development programme.
Franklin Templeton is introducing two actively-managed fixed income ETFs in Europe.
The portfolio is a new sub-fund of the Ucits-qualifying Luxembourg-domiciled Goldman Sachs Funds Sicav.
Invesco has dropped charging on its US equities sector exchange traded funds (ETFs), including its S&P US Technology Sector Ucits.
Legal & General Investment Management has launched a multi-asset fund targeted at defined contribution (DC) investors seeking an ESG option.
A sub-advised mandate run by Neil Woodford has fallen by almost a fifth over the last year delivering investors worse results than his own in-house fund.
Blackrock has written to investors to announce it is expanding the use of derivatives on its Luxembourg and UK domiciled retail fund ranges.
Large Russia exposure is being blamed for unexpectedly high shareholder interest in a tender offer in Blackrock Emerging Europe, which is now set to shut up shop.
A recently-launched RobecoSAM global credit strategy will use top-down views but have an ethical requirement for companies to contribute to the Sustainable Development Goals results in some sector biases.
UBS Global Wealth Management has partnered with Hermes Investment Management to create a Sustainable Development Goal (SDG) fund that will form part of what it claims to be the UK’s first 100% sustainable portfolio.
Lindsell Train has defended its use of a government bond benchmark for its eponymous investment trust as it rakes in £2.8m in performance fees.